HIV, AIDS, and zidovudine
- 28 March 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 339 (8796) , 805-806
- https://doi.org/10.1016/0140-6736(92)91929-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapyJournal of Medical Virology, 1991
- AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease.Proceedings of the National Academy of Sciences, 1991
- Factors influencing outcome of treatment with zidovudine of patients with AIDS in AustraliaAIDS, 1990
- Quantitation of Human Immunodeficiency Virus in the BloodNew England Journal of Medicine, 1990
- Plasma Viremia in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987